WBC Count

White blood cells are immune cells that move through your bloodstream. A WBC count is one of the most common low-cost blood tests we have. It can rise when you're fighting an infection. When it stays high without an obvious short-term cause, it can also reflect chronic inflammation.

That second use is the less obvious one. In large cohorts, higher counts predicted earlier death and more heart disease after researchers accounted for smoking and major prior illness. So it can do more than answer, "am I fighting something today?"

What the Number Actually Is

Your WBC count is the number of white blood cells in a small measured amount of whole blood. It comes from a complete blood count. You'll usually see this called a CBC.

Bone marrow is the tissue inside your bones that makes blood cells. Cholesterol and glucose are molecules. WBC count is a headcount of cells your marrow has made and released.

Those cells come in five main types: neutrophils, lymphocytes, monocytes, eosinophils, and basophils. Neutrophils usually make up the largest share, so the total often rises and falls with them. The total can hide which cell type changed. The differential is the breakdown by type. It usually tells you more than the single total.

Why Higher Counts Track Higher Risk

The clearest reason to care about a resting count has nothing to do with catching a cold. Across big populations, a higher count predicts more heart disease and earlier death, and the link holds after accounting for smoking and existing illness.

Sources: Women's Health Initiative (Kabat et al., 2017); Cardiac ICU cohort (Smith et al., 2024); Diabetes and coronary artery disease cohort (Kawabe et al., 2021).

A count that sits toward the high end of your usual range, with no infection or medication to explain it, is a reason to look for the common drivers of chronic inflammation. The signal also repeats in people who already have heart trouble. In an Asian subgroup of a stable coronary heart disease trial, those with higher counts had about two and a half times the risk of a major heart event over four years.

Both Too High and Too Low Carry Risk

Here the simple reading breaks down. In a long-running aging study, the lowest death rates were in people in the middle of the distribution, while both unusually low and unusually high counts came with higher mortality. This is not a "lower is always better" marker.

A high count usually reflects infection, inflammation, physical stress, or a medication effect. A very low one can mean your bone marrow is making too few white cells, or that a medication is suppressing them. The two ends of the range point to different problems. Context decides what your result is telling you.

Infection: Useful, but Not a Verdict

In the emergency room, WBC counts still earn their keep for suspected infection, especially when read with the differential. One subtype, eosinophils, can drop sharply during bacterial infection. Eosinopenia means the eosinophil count is very low. In one ED study, deep eosinopenia was uncommon in people without bacterial infection, with about 94% specificity, and it was most useful for urinary and gallbladder or bile-duct infections. A larger 2026 study put its specificity closer to 88% and found it trailed CRP, so eosinopenia works best as a rule-in clue rather than a standalone test.

But a high count alone doesn't prove infection, and a normal one doesn't rule it out. In more than 17,000 feverish children, a raised count caught only about half of serious bacterial infections. C-reactive protein is a blood protein that rises with inflammation. You'll usually see it as CRP. CRP did better, and adding WBC to CRP did not improve the prediction. In severe COVID-19, higher counts on admission tracked with worse outcomes, but that reflected illness severity rather than diagnosis.

Cancer, Pregnancy, and Other Signals

A high count is rarely a sign of cancer, and that is a common worry worth settling. In a study of over 400,000 cancer-free adults in the UK Biobank, higher counts were only modestly linked to later cancer overall. The stronger signal was for chronic lymphocytic leukemia and small lymphocytic leukemia, where abnormal white cells may already be present before diagnosis.

The real exception is leukemia. In leukemia, white cells themselves are cancerous. Counts can climb very high, and acute myeloid leukemia with extreme counts is a medical emergency because blood flow and clotting can be affected.

Pregnancy raises the count on its own, usually early, and neutrophils drive most of the rise. That is expected. This is why pregnancy needs pregnancy-specific interpretation. Higher counts during pregnancy have also been linked with complications such as pre-eclampsia, gestational diabetes, preterm birth, and low birth weight. Those findings are observational, so the count is a clue, not a diagnosis.

When One Reading Can Fool You

A single count is a snapshot of a moving target, and several everyday things shift it without meaning your health has changed.

• Recent illness, injury, or surgery: these can push counts up for days, then they settle as you recover. A draw taken soon after won't reflect your baseline.
• Pregnancy: counts run higher than usual, so a value that looks elevated may be expected for that stage.
• Medications: steroids can raise the count by moving neutrophils into the bloodstream. Chemotherapy and immune-suppressing drugs can lower it. The number may be showing the drug effect, not a new disease.
• Your inherited baseline: some people naturally run low because of inherited white-cell patterns. A stable low count can be benign when the differential and history fit.
• Where and how it's measured: hospitalized people without infection, cancer, or immune disease can run above outpatient cutoffs. Automated counters can rarely misclassify particles or abnormal cells. A surprising result is worth repeating before you act on it.

Why One Reading Is Not Enough

Because so much moves the count short term, your own trend over time beats any single value or textbook cutoff. A stable count across years tells a different story than one creeping up, even if both sit inside the lab's range. This matters most for the slow-inflammation signal, where direction matters more than one isolated result.

The differential is the next layer. If the total changed, the useful question is which cell type moved: neutrophils, lymphocytes, monocytes, eosinophils, or basophils. That is where infection patterns, medication effects, allergy signals, and marrow problems start to separate.